Hospital News and Research

RSS

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

Albert Einstein College of Medicine researchers have been awarded a five-year, $3.5 million grant from the National Institutes of Health to study the effects of COVID-19 on the brains of adults who had mild or asymptomatic infection.

8 Jun 2022

New diagnostic procedure could help start optimal stroke treatment in a timely manner

A blood clot in the brain that blocks the supply of oxygen can cause an acute stroke. In this case, every minute counts.

8 Jun 2022

Simple diagnostic procedure and treatment could be life-changing for women struggling with infertility

A simple diagnostic procedure, followed by an interventional radiology treatment known as fallopian tube recanalization, could allow a high percentage of women struggling with infertility from blocked fallopian tubes to conceive with less involved or, in some cases, no further invasive fertility procedures, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting.

8 Jun 2022

Pregnant women's alcohol use correlates with their partner's drinking habits

Pregnant women's use of alcohol correlates with that of their partner, a new study from the University of Eastern Finland and Kuopio University Hospital shows.

8 Jun 2022

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

De novo-designed mini-protein against SARS-CoV-2

Researchers characterized truncated forms of LCB1, a de novo-designed mini-protein, against SARS-CoV-2.

7 Jun 2022

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices to people with diabetes like Sabrina Caudillo.

7 Jun 2022

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on influenza vaccination.

7 Jun 2022

The risk of developing incident diabetes following hospital discharge or at least 28 days after COVID-19 diagnosis

Researchers evaluated the risk of developing incident diabetes mellitus post-acute phase of COVID-19.

7 Jun 2022

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

7 Jun 2022

Genetic testing results in lower length of stay in the NICU for infants with epilepsy

Genetic testing results in lower length of stay in the neonatal intensive care unit (NICU) for infants with epilepsy, according to a study published in the journal Pediatric Neurology.

7 Jun 2022

$Ultrasound-derived fat fraction is linked to MRI proton-density fat fraction and helps detect hepatic steatosis$

Ultrasound-derived fat fraction is linked to MRI proton-density fat fraction and helps detect hepatic steatosis

According to ARRS' American Journal of Roentgenology (AJR), ultrasound-derived fat fraction (UDFF) is strongly associated with MRI proton-density fat fraction (PDFF) and provides high sensitivity for detecting hepatic steatosis.

7 Jun 2022

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer.

6 Jun 2022

Monkeypox virus transmission via sexual contact

A new study discusses the transmission of monkeypox through sexual contact.

6 Jun 2022

Anesthetists play an integral role in reducing preventable maternal mortality in the UK

In a session at this year's Euroanaesthesia, Obstetric Anaesthesia Expert Dr Nuala Lucas (Northwick Park Hospital, London, UK) will examine the key messages for anesthesia practice from the UK's Maternal Mortality Reports which are produced annually to provide robust information about the causes of maternal deaths to promote learning and further reduce preventable maternal mortality in the UK and beyond.

6 Jun 2022

Study evaluates the impact of COVID-19 pandemic on postpartum depression

Despite increase stressors during the COVID-19 pandemic, a new study did not find a higher incidence of postpartum depression among women who gave birth during the pandemic.

6 Jun 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Hospital News and Research

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

New diagnostic procedure could help start optimal stroke treatment in a timely manner

Simple diagnostic procedure and treatment could be life-changing for women struggling with infertility

Pregnant women's alcohol use correlates with their partner's drinking habits

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

De novo-designed mini-protein against SARS-CoV-2

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

The risk of developing incident diabetes following hospital discharge or at least 28 days after COVID-19 diagnosis

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Genetic testing results in lower length of stay in the NICU for infants with epilepsy

Ultrasound-derived fat fraction is linked to MRI proton-density fat fraction and helps detect hepatic steatosis

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Monkeypox virus transmission via sexual contact

Anesthetists play an integral role in reducing preventable maternal mortality in the UK

Study evaluates the impact of COVID-19 pandemic on postpartum depression

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News